Last reviewed · How we verify

NCT05990101: Hyper-AP

HYPoxaEmic Respiratory Failure and Awake Prone Ventilation

Recruiting now NA Last updated 14 August 2023
What this trial tests

NA trial testing Awake prone position (APP) in Respiratory Failure in 262 participants. Currently enrolling.

Timeline
12 May 2023
Primary endpoint
1 August 2026
1 September 2028

Quick facts

Lead sponsorVilnius University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment262
Start date12 May 2023
Primary completion1 August 2026
Estimated completion1 September 2028
Sites4 locations across United Kingdom, Lithuania

Drugs / interventions tested

Conditions studied

Sponsor

Vilnius University

Who can join

18 and older, any sex, with Respiratory Failure or Hypoxemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this prospective multi-centre randomised controlled trial is to determine if addition of awake prone positioning to standard oxygen, high flow oxygen therapy and non-invasive ventilation may reduce the rates of endotracheal intubation and mechanical ventilation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Respiratory Failure

Currently open trials in the same condition.

Other Vilnius University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05990101.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing